Smith W Bradford
SEC insider (Form 3/4/5 filer). CIK 0001317678. Director at Lyra Therapeutics, Inc. (LYRA). 2 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in WATERTOWN, MA.
Companies Smith W Bradford has filed insider reports for
- Lyra Therapeutics, Inc. (LYRA): Director
Smith W Bradford
CIK: 0001317678
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LYRA
Lyra Therapeutics, Inc.
Director